Supervised Injecting Room Cohort Study (SIRX): study protocol

SuperMIX Study (599/21) and SIRX-R Study (71/23) ethics approvals were obtained from Alfred Hospital Research Ethics Committee. Participants will be assessed for capacity to provide informed consent following a detailed explanation of the study. Participants are informed of their right to withdraw from the study at any time and that withdrawing does not impact their access to services. Aggregated research results will be disseminated via presentations at national and international scientific conferences and publications in peer-reviewed journals. Local-level reports and outputs will be distributed to key study stakeholders and policymakers. Summary findings via accessible outputs (eg, short infographic summaries) for participants will be displayed in relevant services including the Melbourne MSIR and the study van, and distributed via Harm Reduction Victoria.

Authors

Institutions

Publication Details

Journal
BMJ Open
Published
2025-02-01
DOI
https://doi.org/10.1136/bmjopen-2024-091337
Primary Topic
HIV, Drug Use, Sexual Risk
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Supervised Injecting Room Cohort Study (SIRX): study protocol

Matthew Hickman, Sione Crawford, Nicolas Clark, Alexander Thompson et al.
BMJ Open
HIV, Drug Use, Sexual Risk
article

Supervised Injecting Room Cohort Study (SIRX): study protocol

Matthew Hickman, Sione Crawford, Nicolas Clark, Alexander Thompson, Nick Scott, Peter Higgs, Amanda Roxburgh, Ashleigh C. Stewart, Paul Dietze, Thomas A. Kerr, Josephine Norman, Paul A. Agius, Mark A Stoove, Daniel O’Keefe, Lisa Maher, Dylan Vella-Horne, Jack Stone, Zachary Lloyd
article en

Abstract

SuperMIX Study (599/21) and SIRX-R Study (71/23) ethics approvals were obtained from Alfred Hospital Research Ethics Committee. Participants will be assessed for capacity to provide informed consent following a detailed explanation of the study. Participants are informed of their right to withdraw from the study at any time and that withdrawing does not impact their access to services. Aggregated research results will be disseminated via presentations at national and international scientific conferences and publications in peer-reviewed journals. Local-level reports and outputs will be distributed to key study stakeholders and policymakers. Summary findings via accessible outputs (eg, short infographic summaries) for participants will be displayed in relevant services including the Melbourne MSIR and the study van, and distributed via Harm Reduction Victoria.

BMJ OpenVol. 15(2)
University of British Columbia (CA), Burnet Institute (AU), Deakin University (AU), The University of Melbourne (AU), La Trobe University (AU), Government of Western Australia Department of Health (AU), University of Bristol (GB), St Vincent's Hospital Melbourne (AU), British Columbia Centre on Substance Use (CA), Monash University (AU)
Gilead Sciences, Burnet Institute, Indivior, Medical Research Council, National Health and Medical Research Council
Good health and well-being
Openalex Percentile: Top 96%
HIV, Drug Use, Sexual Risk
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.